# Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Heart Failure With Reduced Ejection Fraction（PRIME-HFrEF Study）

> **NCT04992832** · PHASE1,PHASE2 · COMPLETED · sponsor: **Shanghai East Hospital** · enrollment: 40 (actual)

## Conditions studied

- Heart Failure, Systolic

## Interventions

- **BIOLOGICAL:** human umbilical cord mesenchymal stem cells
- **OTHER:** human serum albumin

## Key facts

- **NCT ID:** NCT04992832
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-28
- **Primary completion:** 2023-01-17
- **Final completion:** 2023-04-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04992832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04992832, "Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Heart Failure With Reduced Ejection Fraction（PRIME-HFrEF Study）". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04992832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*